[go: up one dir, main page]

UA43351C2 - Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот - Google Patents

Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот

Info

Publication number
UA43351C2
UA43351C2 UA96030972A UA96030972A UA43351C2 UA 43351 C2 UA43351 C2 UA 43351C2 UA 96030972 A UA96030972 A UA 96030972A UA 96030972 A UA96030972 A UA 96030972A UA 43351 C2 UA43351 C2 UA 43351C2
Authority
UA
Ukraine
Prior art keywords
chocolate
fat
cocoa
composition
content
Prior art date
Application number
UA96030972A
Other languages
English (en)
Russian (ru)
Inventor
Міхаєль Шварц
Габрієла Перганде
Юрген ЕНГЕЛЬ
Юрген Энгель
Бернд Нікель
Бернд Никель
Хайнц Ульріх
Штефан Зелені
Original Assignee
Аста Медіка Акцієнгезельшафт
Аста Медика Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аста Медіка Акцієнгезельшафт, Аста Медика Акциенгезельшафт filed Critical Аста Медіка Акцієнгезельшафт
Publication of UA43351C2 publication Critical patent/UA43351C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
UA96030972A 1993-08-17 1994-10-08 Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот UA43351C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4327516A DE4327516A1 (de) 1993-08-17 1993-08-17 Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
PCT/EP1994/002649 WO1995005175A1 (en) 1993-08-17 1994-08-10 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases

Publications (1)

Publication Number Publication Date
UA43351C2 true UA43351C2 (uk) 2001-12-17

Family

ID=6495312

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96030972A UA43351C2 (uk) 1993-08-17 1994-10-08 Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот

Country Status (27)

Country Link
US (1) US5721258A (uk)
EP (1) EP0716602B1 (uk)
JP (1) JPH09501664A (uk)
KR (1) KR100341952B1 (uk)
CN (1) CN1086291C (uk)
AT (1) ATE210442T1 (uk)
AU (1) AU694447B2 (uk)
BG (1) BG62430B1 (uk)
BR (1) BR9407293A (uk)
CA (1) CA2169718C (uk)
CZ (1) CZ289040B6 (uk)
DE (2) DE4327516A1 (uk)
DK (1) DK0716602T3 (uk)
EE (1) EE03204B1 (uk)
ES (1) ES2168309T3 (uk)
HR (1) HRP940464A2 (uk)
HU (1) HU227765B1 (uk)
IL (1) IL110681A (uk)
NO (1) NO309842B1 (uk)
NZ (1) NZ273292A (uk)
PT (1) PT716602E (uk)
RU (1) RU2166318C2 (uk)
SK (1) SK283330B6 (uk)
UA (1) UA43351C2 (uk)
WO (1) WO1995005175A1 (uk)
YU (1) YU49215B (uk)
ZA (1) ZA946176B (uk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
DE19541405A1 (de) * 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
EP1034783B1 (en) 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
AU1359801A (en) * 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
AU1353901A (en) * 1999-12-01 2001-06-12 Duke University Method of treating batten disease
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
CA2550023C (en) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
US20080287399A1 (en) * 2004-12-14 2008-11-20 Astrazeneca Ab Substituted Aminopyridines and Uses Thereof
EP1688141A1 (en) 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20060258708A1 (en) * 2005-05-16 2006-11-16 Andrulis Peter J Jr Method for treating Parkinson's disease and other neurological diseases
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102011006425A1 (de) 2010-03-31 2011-10-06 Awd.Pharma Gmbh & Co. Kg Pharmazeutische Zubereitung und deren Verwendung
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
JP2016527270A (ja) * 2013-07-31 2016-09-08 テバ ファーマシューティカル インダストリーズ リミティド ラキニモドおよびフルピルチンの組合せによる多発性硬化症の治療
US11369593B2 (en) * 2017-07-14 2022-06-28 Texas Tech University System Functionalized pyridine carbamates with enhanced neuroprotective activity
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen
CN120346203A (zh) * 2025-06-23 2025-07-22 西安交通大学 GluK1受体激动剂在制备治疗慢性疼痛的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3337593A1 (de) * 1982-10-27 1984-05-03 Degussa Ag, 6000 Frankfurt 2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
DE3369315D1 (en) * 1982-10-27 1987-02-26 Degussa Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
ZA911553B (en) * 1990-03-02 1991-12-24 Oregon State Tri-and tetra-substituted guanidines and their use as excitatory amino acid and antagonists
IN172468B (uk) * 1990-07-14 1993-08-14 Asta Medica Ag
IL111240A (en) * 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
BG62430B1 (bg) 1999-11-30
KR100341952B1 (ko) 2003-04-11
EP0716602B1 (en) 2001-12-12
HUT75650A (en) 1997-05-28
SK21496A3 (en) 1997-01-08
CN1129399A (zh) 1996-08-21
ATE210442T1 (de) 2001-12-15
EP0716602A1 (en) 1996-06-19
CN1086291C (zh) 2002-06-19
DK0716602T3 (da) 2002-03-25
US5721258A (en) 1998-02-24
HU227765B1 (en) 2012-02-28
DE69429435D1 (de) 2002-01-24
KR960703591A (ko) 1996-08-31
PT716602E (pt) 2002-05-31
DE69429435T2 (de) 2002-06-13
HRP940464A2 (en) 1997-06-30
YU51294A (sh) 1998-05-15
JPH09501664A (ja) 1997-02-18
SK283330B6 (sk) 2003-06-03
CZ289040B6 (cs) 2001-10-17
EE03204B1 (et) 1999-08-16
CA2169718C (en) 2002-11-12
WO1995005175A1 (en) 1995-02-23
NO960607L (no) 1996-02-15
ES2168309T3 (es) 2002-06-16
IL110681A0 (en) 1994-11-11
NZ273292A (en) 1999-09-29
RU2166318C2 (ru) 2001-05-10
BR9407293A (pt) 1996-10-01
CA2169718A1 (en) 1995-02-23
AU694447B2 (en) 1998-07-23
DE4327516A1 (de) 1995-02-23
IL110681A (en) 1999-08-17
HU9600355D0 (en) 1996-04-29
NO309842B1 (no) 2001-04-09
BG100356A (bg) 1996-07-31
NO960607D0 (no) 1996-02-15
CZ46596A3 (en) 1996-05-15
ZA946176B (en) 1995-03-20
AU7652894A (en) 1995-03-14
YU49215B (sh) 2004-11-25

Similar Documents

Publication Publication Date Title
UA43351C2 (uk) Діюча речовина медичних та фармакологічних засобів з активністю антагоніста ексайторних амінокислот
US8728553B2 (en) Vitamin containing product
RU2000125684A (ru) Пищевые продукты, имеющие повышенное содержание полифенолов какао, и способы их производства
US6287624B1 (en) Foods containing fat or oil
GR3018412T3 (en) Milk chocolate and method of making the same
EP0930019A2 (en) Composition for treating obesity and foods and drinks containing the same
EP0553389A1 (en) A cookie with a high cereal content
US6376002B1 (en) Method for preparation of mulberry leaf powder and ice cream containing thereof
EP0477935A1 (en) Use of diglycerides in chocolate mixtures
AU2016280299B2 (en) Low calorie food compositions
EP1958522B1 (en) Functional food having positive effects in the prevention of cardiovascular diseases
EP1937078B1 (en) High milk solid chocolate composition
US3062655A (en) Water insoluble defibrillated meat protein
US10045555B2 (en) Shelf-stable spreadable cream
JP4390376B2 (ja) 水中油型乳化チョコレート類及びこれを用いた複合食品
JPH1198952A (ja) 油脂含有食品及びその製造方法
EP0388237A2 (en) Dietary product
EP0509509A1 (en) Frozen dessert in which cocoa butter is used
JPH07322825A (ja) 健康アイスクリーム及びその製造方法
JP2950191B2 (ja) 油脂組成物及びそれを含む水中油型乳化物
RU2121798C1 (ru) Масса пралине для конфет и способ производства конфет из массы пралине
KR19980072453A (ko) 상백피를 주성분으로 함유하는 당뇨환자용 과자류 조성물
RU2112389C1 (ru) Способ повышения пищевой ценности продукта питания
EP0589940B1 (en) Monounsaturated dairy products
JPH07108188B2 (ja) チョコレート類の製造法